AAAAAA
Results:
1-23
|
Results: 23
Authors:
HERMANSEN F
ROSEN SD
FATHORDOUBADI F
KOONER JS
CLARK JC
CAMICI PG
LAMMERTSMA AA
Citation: F. Hermansen et al., MEASUREMENT OF MYOCARDIAL BLOOD-FLOW WITH O-15 LABELED WATER - COMPARISON OF DIFFERENT ADMINISTRATION PROTOCOLS, European journal of nuclear medicine, 25(7), 1998, pp. 751-759
Authors:
FATHORDOUBADI F
BEATT KJ
Citation: F. Fathordoubadi et Kj. Beatt, GLUCOSE-INSULIN-POTASSIUM THERAPY FOR TREATMENT OF ACUTE MYOCARDIAL-INFARCTION - REPLY, Circulation, 97(22), 1998, pp. 2278-2279
Authors:
FATHORDOUBADI F
PAGANO D
MARINHO NVS
KEOGH BE
BONSER RS
CAMICI PG
Citation: F. Fathordoubadi et al., CORONARY REVASCULARIZATION IN THE TREATMENT OF MODERATE AND SEVERE POSTISCHEMIC LEFT-VENTRICULAR DYSFUNCTION, The American journal of cardiology, 82(1), 1998, pp. 26-31
Authors:
BEATT KJ
FATHORDOUBADI F
Citation: Kj. Beatt et F. Fathordoubadi, ANGIOPLASTY FOR THE TREATMENT OF ACUTE MYOCARDIAL-INFARCTION, HEART, 78, 1997, pp. 12-15
Authors:
FATHORDOUBADI F
Citation: F. Fathordoubadi, PREDICTIVE VALUE OF FDG IMAGING IN PATIENTS WITH CHRONIC ISCHEMIC LEFT-VENTRICULAR DYSFUNCTION ENROLLED IN A PROSPECTIVE EUROPEAN MULTICENTER VIABILITY STUDY, Journal of the American College of Cardiology, 29(2), 1997, pp. 14147-14147
Authors:
FATHORDOUBADI F
VANDERWATT MJ
NOBLE MIM
Citation: F. Fathordoubadi et al., EARLY PRESENTATION OF DILATED CARDIOMYOPATHY AS A PART OF SEROCONVERSION ILLNESS IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, Clinical cardiology, 20(8), 1997, pp. 738-739
Authors:
FATHORDOUBADI F
BEATT KJ
Citation: F. Fathordoubadi et Kj. Beatt, A COMPARISON OF THROMBOLYTIC THERAPY WITH PRIMARY CORONARY ANGIOPLASTY FOR ACUTE MYOCARDIAL-INFARCTION, The New England journal of medicine, 336(15), 1997, pp. 1103-1104
Authors:
FATHORDOUBADI F
LANE RJM
RICHARDS PG
Citation: F. Fathordoubadi et al., HISTOLOGICAL SURPRISE - CALLOSAL TUBERCULOMA PRESENTING AS MALIGNANT GLIOMA, Journal of Neurology, Neurosurgery and Psychiatry, 63(1), 1997, pp. 98-99
Authors:
PAGANO D
FATHORDOUBADI F
TOWNEND JN
BEATT KJ
BONSER RS
CAMICI PG
Citation: D. Pagano et al., HIBERNATING MYOCARDIUM IS CHARACTERIZED BY AN IMPAIRED CORONARY VASODILATOR RESERVE, Circulation, 96(8), 1997, pp. 3497-3497
Authors:
FATHORDOUBADI F
DRAKE A
BEATT KJ
SPYROU N
DAVIES DW
Citation: F. Fathordoubadi et al., LONG-TERM AMIODARONE THERAPY FOLLOWING MYOCARDIAL-INFARCTION - OVERVIEW OF RANDOMIZED CONTROLLED TRIALS, Circulation, 96(8), 1997, pp. 3949-3949
Authors:
FATHORDOUBADI F
BEATT KJ
Citation: F. Fathordoubadi et Kj. Beatt, GLUCOSE-INSULIN-POTASSIUM THERAPY FOR TREATMENT OF ACUTE MYOCARDIAL-INFARCTION - AN OVERVIEW OF RANDOMIZED PLACEBO-CONTROLLED, Circulation, 96(4), 1997, pp. 1152-1156
Authors:
FATHORDOUBADI F
HUEHNS TY
ALMOHAMMAD A
BEATT KJ
Citation: F. Fathordoubadi et al., SIGNIFICANCE OF THE THROMBOLYSIS IN MYOCARDIAL-INFARCTION SCORING SYSTEM IN ASSESSING INFARCT-RELATED ARTERY REPERFUSION AND MORTALITY-RATES AFTER ACUTE MYOCARDIAL-INFARCTION, The American heart journal, 134(1), 1997, pp. 62-68
Authors:
FATHORDOUBADI F
ALMOHAMMAD A
HEUHNS TY
DANA A
BEATT KJ
Citation: F. Fathordoubadi et al., PREHOSPITAL VERSUS HOSPITAL THROMBOLYSIS - AN OVERVIEW OF RANDOMIZED TRIALS, HEART, 75(5), 1996, pp. 169-169
Authors:
FATHORDOUBADI F
BEATT KJ
Citation: F. Fathordoubadi et Kj. Beatt, GLUCOSE-INSULIN-POTASSIUM (GIK) THERAPY FOR ACUTE MYOCARDIAL-INFARCTION - OVERVIEW OF RANDOMIZED PLACEBO-CONTROLLED TRIALS, HEART, 75(5), 1996, pp. 174-174
Authors:
FATHORDOUBADI F
SPYROU N
BEATT KJ
Citation: F. Fathordoubadi et al., CORONARY ANGIOPLASTY FOR THE TREATMENT OF CHRONIC LEFT-VENTRICULAR DYSFUNCTION - PREDICTIVE VALUE OF POSITRON EMISSION TOMOGRAPHY AND THE EFFECT OF RESTENOSIS, Circulation, 94(8), 1996, pp. 1460-1460
Authors:
FATHORDOUBADI F
SPYROU N
PAGANO D
BEATT KJ
Citation: F. Fathordoubadi et al., DOBUTAMINE ECHOCARDIOGRAPHY AND POSITRON EMISSION TOMOGRAPHY FOR ASSESSING VIABILITY IN PATIENTS WITH MODERATE VENTRICULAR DYSFUNCTION, Circulation, 94(8), 1996, pp. 3173-3173
Authors:
FATHORDOUBADI F
BEATT KJ
Citation: F. Fathordoubadi et Kj. Beatt, GLUCOSE-INSULIN-POTASSIUM (GIK) THERAPY FOR TREATMENT OF ACUTE MYOCARDIAL-INFARCTION - HAS IT BEEN ABANDONED TOO EARLY, Circulation, 92(8), 1995, pp. 112-112
Authors:
FATHORDOUBADI F
BEATT KJ
Citation: F. Fathordoubadi et Kj. Beatt, ACUTE MYOCARDIAL-INFARCTION - STRATEGIES FOR THROMBOLYTIC THERAPY, British Journal of Hospital Medicine, 53(11), 1995, pp. 575
Authors:
FATHORDOUBADI F
BEATT KJ
Citation: F. Fathordoubadi et Kj. Beatt, FIBRINOLYTIC THERAPY IN SUSPECTED ACUTE MYOCARDIAL-INFARCTION, Lancet, 343(8902), 1994, pp. 912-912
Authors:
FATHORDOUBADI F
Citation: F. Fathordoubadi, PREHOSPITAL THROMBOLYTIC THERAPY FOR MYOCARDIAL-INFARCTION, The New England journal of medicine, 330(4), 1994, pp. 290-291
Authors:
FATHORDOUBADI F
Citation: F. Fathordoubadi, PREHOSPITAL THROMBOLYTIC THERAPY FOR MYOCARDIAL-INFARCTION (VOL 330, PG 290, 1994), The New England journal of medicine, 330(13), 1994, pp. 947-947
Authors:
FATHORDOUBADI F
BEATT KJ
Citation: F. Fathordoubadi et Kj. Beatt, ANGIOPLASTY AND ACUTE MYOCARDIAL-INFARCTION, Lancet, 342(8875), 1993, pp. 861-862
Authors:
FATHORDOUBADI F
Citation: F. Fathordoubadi, THE FLOSEQUINAN EXPERIENCE AND ITS IMPLICATIONS, British Journal of Hospital Medicine, 50(11), 1993, pp. 683-683
Risultati:
1-23
|